Showing results (121-130 of 137) with videos related to

Sort By:
Pageof 14
The Lancet. Respiratory Medicine|January 14, 2021
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort studyRishi K Gupta, Ewen M Harrison, Antonia Ho, et al.
Viruses|October 17, 2020
Amplicon-Based Detection and Sequencing of SARS-CoV-2 in Nasopharyngeal Swabs from Patients With COVID-19 and Identification of Deletions in the Viral Genome That Encode Proteins Involved in Interferon AntagonismShona C Moore, Rebekah Penrice-Randal, Muhannad Alruwaili, et al.
Brain : a Journal of Neurology|September 6, 2022
Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responsesEdward J Needham, Alexander L Ren, Richard J Digby, et al.
Pathogens & Immunity|May 20, 2026
Impact of Sex on Viral Shedding and Symptom Severity During Acute COVID-19Evelyn Kung, Rinki Deo, Manish C Choudhary, et al.
Nature Communications|August 22, 2022
Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19Kara W Chew, Carlee Moser, Eric S Daar, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2026
Viral shedding and symptom severity across populations during acute COVID in the ACTIV-2 studyEvelyn Kung, Rinki Deo, Manish C Choudhary, et al.
JAMA Network Open|April 26, 2023
Safety and Efficacy of Combined Tixagevimab and Cilgavimab Administered Intramuscularly or Intravenously in Nonhospitalized Patients With COVID-19: 2 Randomized Clinical TrialsRachel A Bender Ignacio, Kara W Chew, Carlee Moser, et al.
Elife|October 5, 2022
An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patientsBronner P Gonçalves, Matthew Hall, Waasila Jassat, et al.
Open Forum Infectious Diseases|September 22, 2025
Rapid Elimination of Culturable SARS-CoV-2 With Intramuscular or Intravenous Administration of Antiviral Monoclonal Antibody TherapyRinki Deo, Manish C Choudhary, Owen T Glover, et al.
Plos Pathogens|June 14, 2012
Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escapeKatharine J Bar, Chun-yen Tsao, Shilpa S Iyer, et al.
Pageof 14